Related Experiment Video
Updated: Jul 10, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Relapse prevention in schizophrenia - new therapeutic challenges
Abdulah Kucukalić1, Alma Dzubur-Kulenović, Enra Mehmedika-Suljić
1Department of Psychiatry, University of Sarajevo Clinical Center, Bolnicka 25, 71,000 Sarajevo, Bosnia & Herzegovina.
Psychiatria Danubina
|November 15, 2007
Summary
Early and individualized treatment with antipsychotics, especially atypical depot injections, improves long-term outcomes for schizophrenia patients by reducing relapses and enhancing quality of life.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Schizophrenia is a leading cause of global disability, often underestimated.
- Characterized by cognitive decline, high suicide rates, and frequent relapses.
- Requires long-term management and individualized treatment approaches.
Purpose of the Study:
- To review evidence on early and optimal treatment strategies for schizophrenia.
- To emphasize the importance of individualized patient care and antipsychotic selection.
- To highlight the benefits of atypical antipsychotics, particularly depot formulations.
Main Methods:
- Literature review of studies on schizophrenia treatment outcomes.
- Analysis of factors influencing treatment response and adherence.
- Evaluation of antipsychotic efficacy, safety, and tolerability.
Main Results:
- Early antipsychotic treatment improves long-term outcomes.
- Individualized approaches are crucial due to patient variability.
- Atypical antipsychotics, especially depot injections, enhance treatment adherence and efficacy.
Conclusions:
- Initiating adequate antipsychotic doses early, even in prodromal psychosis, is recommended.
- Atypical antipsychotics offer sustained symptom control, reduced hospitalizations, and improved quality of life.
- Establishing a strong therapeutic alliance is key for successful long-term schizophrenia management.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...